The non-nucleoside reverse transcriptase inhibitor antiretroviral therapy for HIV/AIDS may yield significantly higher rates of drug resistance compared with protease inhibitors and nucleoside reverse transcriptase inhibitors, a new study shows.
In immunocompromised patients with systemic rheumatic diseases, daily half-strength sulfamethoxazole-trimethoprim (SMX/TMP) appears to be an optimal regimen for chemoprophylaxis of Pneumocystis pneumonia (PJP), according to a study.
Atopic dermatitis (AD) during infancy is associated with an increased risk of developing tooth decay by age three, according to results from the GUSTO* study.
The Department of Health 2016 data reports that there are 29 newly-diagnosed cases of HIV in the Philippines everyday, majority of whom are between 15 to 24 years old. The HIV epidemic is not only a health problem — it is also a development issue that should be a concern of all Filipinos.
Lowering the dosage of aminoglycosides guided by therapeutic dose monitoring (TDM) may reduce aminoglycoside-related hearing loss, without compromising its efficacy against multidrug resistant tuberculosis (MDR-TB), a recent study suggests.
About one-third of individuals who had previously been diagnosed with asthma were tested negative for the condition upon current reassessment, of which many had their asthma medications safely stopped for another year, reveals a recent study, suggesting a need for reassessment of asthma diagnosis.
Bezlotoxumab, a human monoclonal antibody against Clostridium difficile (C. difficile) toxin B, appears to reduce the risk of recurrent C. difficile infection, according to findings from the MODIFY I* and MODIFY II** trials.
The Philippine influenza surveillance data provides crucial information on seasonality and dominant viral strains for healthcare providers and policymakers, according to a study by Lucero et al.
Cervicovaginal bacterial communities with low Lactobacillus abundance may increase the risk of HIV acquisition in young women, the FRESH* study showed.
Many patients with HIV receiving ongoing treatment frequently engage in recreational drug use, a new cross-sectional study reports. Unfortunately, these substances may interfere with clinical outcomes and may potentially interact with the antiretroviral agents.